Phase II study of neoadjuvant chemoradiotherapy of s-1 and cisplatin for advanced gastric cancer with lymph node metastases (Neo-KOGC04 study)
Not Applicable
- Conditions
- Advanced Gastric Cancer
- Registration Number
- JPRN-UMIN000014331
- Lead Sponsor
- School of Medicine, Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) contraindication of either S-1 or cisplatin 2) with severe infection 3) with interstitial pneumonia or pulmonary fibrosis 4) with severe diarrhea 5) with severe complication (intestinal paralysis, ileus, diabetes, renal dysfunction, liver dysfunction) 6) with other active malignant disease 7) pregnant or nursing women or women who like be pregnant and willing to get pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate of neoadjuvant chemoradiotherapy
- Secondary Outcome Measures
Name Time Method Pathological response rate, compliance of neoadjuvant therapy, compliance of adjuvant therapy, curable resection rate, rate of adverse event, 3-year Relapse-free survival, 3-year Overall survival